e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Pulmonary circulation I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Circulating collagen biomarker and quality of life in pulmonary arterial hypertension
Z. Safdar (Houston, United States Of America)
Source:
Annual Congress 2010 - Pulmonary circulation I
Session:
Pulmonary circulation I
Session type:
Thematic Poster Session
Number:
1113
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Safdar (Houston, United States Of America). Circulating collagen biomarker and quality of life in pulmonary arterial hypertension. Eur Respir J 2010; 36: Suppl. 54, 1113
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Circulating fibrocytes and pulmonary arterial hypertension
Source: Eur Respir J 2011; 39: 210-212
Year: 2012
Circulating fibrocytes and pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 210-212
Year: 2012
Circulating fibrocytes in pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 608-616
Year: 2011
Measurement of quality of life in pulmonary hypertension and its significance
Source: Eur Respir J 2006 Oct 01;28(4):808-815
Year: 2006
Sildenafil improves health-related quality of life in pulmonary arterial hypertension (PAH) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 563s
Year: 2005
Pulmonary arterial hypertension: the burden of disease and impact on quality of life
Source: Eur Respir Rev 2015; 24: 621-629
Year: 2015
LATE-BREAKING ABSTRACT: Circulating collagen indices indicative of disease severity in pulmonary arterial hypertension
Source: Annual Congress 2012 - New insights in pneumology - ERS inter-Assemblies late-breaking abstracts
Year: 2012
Health-related quality of life in patients with pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011
Effects of tadalafil on health-related quality of life in patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009
Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Improving survival in pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 218-220
Year: 2005
Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019
EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR
Source: Eur Respir J, 57 (2) 2000414; 10.1183/13993003.00414-2020
Year: 2021
Exercise tests and anxiety independently reflect physical quality of life in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Apelin improves cardiac output in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
Effect of intravenous epoprostenol on quality of life in pulmonary arterial hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 563s
Year: 2003
Circulating angiopoietins in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Plasma nitrite/nitrate levels: a new biomarker for pulmonary arterial hypertension?
Source: Eur Respir J 2016; 48: 1265-1267
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept